Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Cash from Operations (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Cash from Operations for 16 consecutive years, with 24657000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 7.33% to 24657000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 82484000.0 through Dec 2025, down 350.88% year-over-year, with the annual reading at 82484000.0 for FY2025, 350.88% down from the prior year.
  • Cash from Operations hit 24657000.0 in Q4 2025 for Perspective Therapeutics, down from 16292000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 13848000.0 in Q1 2024 to a low of 26606000.0 in Q4 2024.
  • Historically, Cash from Operations has averaged 7963315.79 across 5 years, with a median of 8072000.0 in 2023.
  • Biggest five-year swings in Cash from Operations: skyrocketed 452.76% in 2021 and later crashed 584.02% in 2025.
  • Year by year, Cash from Operations stood at 2681000.0 in 2021, then crashed by 327.0% to 6086000.0 in 2022, then tumbled by 48.01% to 9008000.0 in 2023, then plummeted by 195.36% to 26606000.0 in 2024, then increased by 7.33% to 24657000.0 in 2025.
  • Business Quant data shows Cash from Operations for CATX at 24657000.0 in Q4 2025, 16292000.0 in Q3 2025, and 19953000.0 in Q2 2025.